Open access
Sep 2026
A multicenter analysis of prognostic factors for patients undergoing re-irradiation for recurrent glioblastoma
Re-irradiation (re-RT) has gained popularity in the treatment of recurrent or progressive glioblastoma (rGBM) after first-line treatment. However, uncertainties regarding optimal treatment dose, fraction size and target volume definition remain. In this multicenter analysis of the Western German Cancer Center (WT...
N. Pepper, M. Guberina, C. Poettgen et al.
· Neuro-Oncology Advances · 0 citations